Neutrophil to lymphocyte ratio predicts risk of nodal involvement in T1 colorectal cancer patients.

BACKGROUND Risk of nodal involvement in T1 colorectal cancer is assessed by tumor histological features. In several tumors, the ratio between neutrophils and lymphocytes (NLR) or platelets and lymphocytes (PLR) have been applied to lymph-node metastases prediction. The aim of this study was to evaluate the role of NLR, derived NLR (dNLR) and PLR in predicting nodal involvement in T1 colorectal cancers. METHODS NLR, dNLR and PLR in surgical resected T1 colorectal cancers were retrospectively calculated and analysed in nodal positive and negative cases. RESULTS Data regarding 102 patients were considered. Nodal involvement rate was 10.8%. NLR values were higher in node positive patients (P=0.04). A trend toward significance (P=0.05) was found for higher dNLR values and positive nodal status. For NLR, ROC curve analysis allowed to choose a predictive cut-off value of 3.7 (AUC of 0.69; 95% CI: 0.48-0.89). Nodal positivity was reported in 71.5% of high NLR patients; only two N0 cases (28.5%) were registered in high NLR group (P<0.001). The logistic regression analysis aimed to evidence the predictive role of high NLR in node positivity resulted in a significant OR of 37.1 (P<0.0001; 95% CI: 0.48-0.89). NLR allowed to distinguish N0 from N1 patients in 99.4% of cases. CONCLUSIONS NLR<3.7 was associated with lower risk of lymph-node metastases in T1 colorectal cancer patients. NLR could be used with histopathological data to identify patients at lower risk of nodal metastases.

[1]  E. Ruíz-García,et al.  Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy , 2016, Medical archives.

[2]  A. Khan,et al.  The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer , 2016, Oncology.

[3]  D. Coit,et al.  Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma , 2016, Annals of surgery.

[4]  P. Gibbs,et al.  Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival. , 2015, Clinical colorectal cancer.

[5]  J. Knox,et al.  Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer. , 2015, Clinical genitourinary cancer.

[6]  M. Orditura,et al.  Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis. , 2015, Surgery.

[7]  J. Yue,et al.  Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer , 2015, Tumor Biology.

[8]  Y. Toiyama,et al.  Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery , 2015, Digestive Diseases and Sciences.

[9]  Peng Wang,et al.  Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[10]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[11]  Y. Toiyama,et al.  Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. , 2015, International surgery.

[12]  N. Kim,et al.  Clinical Implications of Microsatellite Instability in T1 Colorectal Cancer , 2014, Yonsei medical journal.

[13]  Y. Kim,et al.  Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer , 2014, BMC Surgery.

[14]  Yu-qin Pan,et al.  The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients , 2014, Medical Oncology.

[15]  O. Faiz,et al.  A Preoperative Neutrophil to Lymphocyte Ratio of 3 Predicts Disease-Free Survival After Curative Elective Colorectal Cancer Surgery , 2014, Annals of surgery.

[16]  Y. Hirose,et al.  Predictors of Lymph Node Metastasis in T1 Colorectal Carcinoma: An Immunophenotypic Analysis of 265 Patients , 2014, Diseases of the colon and rectum.

[17]  K. Leong,et al.  Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation , 2014, The British journal of surgery.

[18]  H. Ueno,et al.  Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma , 2014, International Journal of Colorectal Disease.

[19]  J. Coffey,et al.  Ratios derived from an array of standard haematological indices predict the oncological outcome in colon cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[20]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[21]  C. Taffon,et al.  T1 colorectal cancer: poor histological grading is predictive of lymph-node metastases. , 2014, International journal of surgery.

[22]  K. Gungorduk,et al.  Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva? , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[23]  H. Samonigg,et al.  Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. , 2013, Anticancer research.

[24]  H. Samonigg,et al.  A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients , 2013, British Journal of Cancer.

[25]  Y. Iwasaki,et al.  Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer , 2013, British Journal of Cancer.

[26]  S. Grossman,et al.  The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme , 2013, Journal of Neuro-Oncology.

[27]  S. Mallappa,et al.  Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[28]  R. Soetikno,et al.  Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis , 2013, Surgical Endoscopy.

[29]  K. Pummer,et al.  Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients , 2013, British Journal of Cancer.

[30]  C. Antonescu,et al.  Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor , 2013, Annals of Surgical Oncology.

[31]  L. Tho,et al.  Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[32]  D. McMillan,et al.  The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer , 2012, PloS one.

[33]  S. Albelda,et al.  Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.

[34]  Jeong-Won Lee,et al.  Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. , 2012, Anticancer research.

[35]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[36]  R. Tang,et al.  Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy , 2011, International Journal of Colorectal Disease.

[37]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[38]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[39]  A. Nicholson,et al.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[40]  J. Galon,et al.  The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. , 2007, Cancer research.

[41]  R. Sinha,et al.  A prospective study of serum C-reactive protein and colorectal cancer risk in men. , 2006, Cancer research.

[42]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[43]  R. Nozaki,et al.  Management of early invasive colorectal cancer , 1995, Diseases of the colon and rectum.

[44]  K. Hase,et al.  Long-term results of curative resection of “minimally invasive” colorectal cancer , 1995, Diseases of the colon and rectum.

[45]  P. Hermanek,et al.  Early (microinvasive) colorectal carcinoma , 1986, International Journal of Colorectal Disease.

[46]  Qiaojia Huang,et al.  The Value of Preoperative Neutrophil to Lymphocyte Ratio in Indicating Lymph Node Metastasis in Patients with Resectable T2 Stage Gastric Adenocarcinoma. , 2016, Clinical laboratory.

[47]  H. Bostanci,et al.  Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer. , 2014, Turkish journal of medical sciences.

[48]  M. Büchler,et al.  Radical Surgery with Total Mesorectal Excision in Patients with T1 Rectal Cancer , 2014, Annals of Surgical Oncology.

[49]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[50]  H. Ohtani Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. , 2007 .

[51]  H. Ohtani,et al.  Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. , 2007, Cancer immunity.